Jones Financial Companies
ANIX icon

Jones Financial Companies’s Anixa Biosciences ANIX Stock Holding History

Jones Financial Companies’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.6K Buy
4,527
+197
+5% +$548 ﹤0.01% 3701
2026
Q1 		$11K Buy
4,330
+500
+13% +$1.48K ﹤0.01% 3545
2025
Q4 		$11.9K Buy
3,830
+1,794
+88% +$7.35K ﹤0.01% 3139
2025
Q3 		$6.92K Buy
+2,036
New +$6.44K ﹤0.01% 3227

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Jones Financial Companies's ANIX Position: Q2 2026 in Review

Jones Financial Companies increased its Anixa Biosciences (ANIX) stake by 4.5% in Q2 2026, buying an estimated $548 and bringing the position to 4,527 shares worth $12.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3701.

Jones Financial Companies first reported a position in ANIX in Q3 2025 and has held it in 4 quarters since. 62 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Jones Financial Companies held 4,527 shares of Anixa Biosciences worth $12.6K as of Q2 2026.
  • Jones Financial Companies bought 197 Anixa Biosciences shares in Q2 2026, an estimated $548.
  • Anixa Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #3701 holding.
  • Jones Financial Companies first reported a position in Anixa Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 62 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.